← ritschelresearch.com

Patent Portfolio

50 USPTO provisional patent applications in computational drug repurposing, AI methodology, and novel inventions. All disease-specific patents use a standardized scRNA-seq pipeline to identify novel drug repurposing candidates.

50
Patents Filed
43
Diseases
10+
Indications for Lead Compound

Cross-Disease Lead Compounds

CHEMBL5653589
#1 across 10+ indications
WZ-3105 (SRC/ABL)
Signal across 20+ pipelines
QL-XII-47 (MELK/FLT3)
6+ independent indications
DASATINIB
Published Phase 1 clinical data
Autoimmune & Inflammatory
18 patents
P01 · 63/990,695 · Feb 25, 2026
Scleroderma (SSc)
scRNA-seq drug repurposing
Spec Paper
P07 · 64/006,744 · Mar 16, 2026
Calcinosis
scRNA-seq drug repurposing
Spec Paper
P08 · 64/007,178 · Mar 16, 2026
Raynaud's Phenomenon
scRNA-seq drug repurposing
Spec Paper
P09 · 64/007,491 · Mar 16, 2026
Esophageal Dysmotility
scRNA-seq drug repurposing
Spec Paper
P10 · 64/008,496 · Mar 17, 2026
Telangiectasia
scRNA-seq drug repurposing
Spec Paper
P11 · 64/009,680 · Mar 18, 2026
Psoriasis
scRNA-seq drug repurposing
Spec Paper
P12 · 64/010,762 · Mar 19, 2026
IBD / Crohn's Disease
scRNA-seq drug repurposing
Spec Paper
P13 · 64/011,008 · Mar 19, 2026
irAE Inflammatory Arthritis
scRNA-seq drug repurposing
Spec Paper
P14 · 64/012,196 · Mar 20, 2026
Autoimmune Hemolytic Anemia
scRNA-seq drug repurposing
Spec Paper
P16 · 64/012,523 · Mar 21, 2026
Atopic Dermatitis
scRNA-seq drug repurposing
Spec Paper
P17 · 64/012,548 · Mar 21, 2026
Systemic Lupus Erythematosus
scRNA-seq drug repurposing
Spec Paper
P19 · 64/012,657 · Mar 21, 2026
Ulcerative Colitis
scRNA-seq drug repurposing
Spec Paper
P30 · 64/018,614 · Mar 27, 2026
Lupus Nephritis
scRNA-seq drug repurposing
Spec Paper
P38 · 64/020,925 · Mar 29, 2026
Rheumatoid Arthritis
scRNA-seq drug repurposing
Spec Paper
P39 · 64/021,948 · Mar 30, 2026
Sjogren's Syndrome
scRNA-seq drug repurposing
Spec Paper
P41 · 64/022,609 · Mar 31, 2026
Dermatomyositis
scRNA-seq drug repurposing
Spec Paper
P43 · 64/025,147 · Apr 1, 2026
Psoriatic Arthritis
scRNA-seq drug repurposing
Spec Paper
P44 · 64/025,679 · Apr 2, 2026
Ankylosing Spondylitis
scRNA-seq drug repurposing
Spec Paper
Neurodegenerative & Neurological
7 patents
P18 · 64/012,619 · Mar 21, 2026
Multiple Sclerosis (CSF)
scRNA-seq drug repurposing
Spec Paper
P20 · 64/012,709 · Mar 21, 2026
Ab-IDD / NMOSD (CSF)
scRNA-seq drug repurposing
Spec Paper
P22 · 64/013,194 · Mar 22, 2026
Migraine (Trigeminal Ganglion / CAMK2A)
scRNA-seq drug repurposing
Spec Paper
P25 · 64/014,341 · Mar 23, 2026
Alzheimer's Disease (SYK / Microglia)
scRNA-seq drug repurposing
Spec Paper
P26 · 64/015,045 · Mar 24, 2026
Parkinson's Disease
scRNA-seq drug repurposing
Spec Paper
P27 · 64/016,256 · Mar 25, 2026
ALS
scRNA-seq drug repurposing
Spec Paper
P28 · 64/016,898 · Mar 25, 2026
Huntington's Disease
scRNA-seq drug repurposing
Spec Paper
P29 · 64/017,924 · Mar 26, 2026
Frontotemporal Dementia
scRNA-seq drug repurposing
Spec Paper
Pulmonary & Respiratory
4 patents
P23 · 64/013,288 · Mar 22, 2026
eCRSwNP / Allergic Rhinitis
scRNA-seq drug repurposing
Spec Paper
P24 · 64/013,443 · Mar 22, 2026
Asthma (Bronchial)
scRNA-seq drug repurposing
Spec Paper
P34 · 64/020,036 · Mar 28, 2026
Idiopathic Pulmonary Fibrosis
scRNA-seq drug repurposing
Spec Paper
P35 · 64/020,546 · Mar 29, 2026
COPD
scRNA-seq drug repurposing
Spec Paper
Gastrointestinal & Hepatic
3 patents
P37 · 64/020,738 · Mar 29, 2026
MASH / Liver Fibrosis
scRNA-seq drug repurposing
Spec Paper
P48 · 64/029,386 · Apr 4, 2026
Eosinophilic Esophagitis
scRNA-seq drug repurposing
Spec Paper
P50 · 64/029,522 · Apr 4, 2026
Gastric Premalignant Lesions
scRNA-seq drug repurposing
Spec Paper
Metabolic & Endocrine
3 patents
P31 · 64/019,209 · Mar 27, 2026
WAT Browning (Obesity)
scRNA-seq drug repurposing
Spec Paper
P33 · 64/019,739 · Mar 27, 2026
Type 1 Diabetes
scRNA-seq drug repurposing
Spec Paper
P40 · 64/022,596 · Mar 31, 2026
Type 2 Diabetes / Pancreatic Islets
scRNA-seq drug repurposing
Spec Paper
Oncology
1 patent
P32 · 64/019,507 · Mar 27, 2026
Glioblastoma (GBM)
scRNA-seq drug repurposing
Spec Paper
Renal
1 patent
P46 · 64/027,911 · Apr 3, 2026
Chronic Kidney Disease
scRNA-seq drug repurposing
Spec Paper
Reproductive
1 patent
P47 · 64/029,152 · Apr 3, 2026
Endometriosis
scRNA-seq drug repurposing
Spec Paper
Cardiovascular
1 patent
P42 · 64/023,736 · Mar 31, 2026
Heart Failure / DCM
scRNA-seq drug repurposing
Spec Paper
Systemic & Multi-Organ
3 patents
P36 · 64/020,635 · Mar 29, 2026
Long COVID / POTS
scRNA-seq drug repurposing
Spec Paper
P45 · 64/026,746 · Apr 2, 2026
Inflammaging
scRNA-seq drug repurposing
Spec Paper
P49 · 64/029,481 · Apr 4, 2026
Sarcoidosis
scRNA-seq drug repurposing
Spec Paper
AI, Platform & Non-Biomedical
7 patents
P02 · 63/990,970 · Feb 25, 2026
Audit of Intent (AI Safety)
AI methodology
Spec
P03 · 63/999,401 · Mar 7, 2026
Printed Refolding
Molecular folding
Spec
P04 · 63/999,671 · Mar 8, 2026
MFOL
Molecular folding
Spec Paper
P05 · 64/000,777 · Mar 9, 2026
Olive Oil Antioxidant Triplet
Nutraceutical
Spec Paper
P06 · 64/005,354 · Mar 13, 2026
Drone Ball
Consumer product
Spec
P15 · 64/012,284 · Mar 20, 2026
Distributed Causal Memory
AI architecture
Spec Paper
P21 · 64/013,074 · Mar 22, 2026
Gut-targeted GABA-A PAM
Therapeutic design
Spec Paper

© 2026 Ritschel Research · glen@ritschelresearch.com

All disease-specific inventions are patent-pending. Patent applications have been filed with the USPTO. No patents have been granted at this time.